NGM Biopharmaceuticals specializes in the discovery and development of medicines for various diseases. The company employs a biology-centric drug discovery approach, integrating complex disease biology with protein engineering to develop product candidates. It treats conditions like hyperemesis gravidarum and cancer cachexia. It was founded in 2008 and is based in South San Francisco, California.

Dialectica offers Neural Stem Cell-based Systems and Assays for drug screening in neurodegenerative diseases. The mission of Dialectica is to add value to the link between research and pharmaceutical and biotechnology companies that are active in the discovery of therapeutics for brain diseases. Dialectica develops and optimize Neural Stem Cell-based Systems and Assays for drug screening in neurodegenerative diseases.

is a contract research organization that collaborates with R&D departments of biotechnology and biopharmaceutical companies to discover and develop new medicines. The company also engages in its own drug discovery agenda to develop treatments of treat tropical diseases such as malaria.

LeukoSight is a biopharmaceutical company focused on developing anti-inflammatory therapeutics for autoimmune and inflammatory diseases. Their main offerings include reprogramming white blood cells to produce immunoregulatory molecules. LeukoSight's initial targets are conditions like multiple sclerosis. It is based in Columbia, Maryland.

Bionovo is a drug development company focusing on the discovery of novel pharmaceutical agents for cancer and women's health. The company's strategy is to develop new drugs that it derives from natural substances used therapeutically in non-western medical practice. Bionovo's first drug is entering phase II clinical testing for menopause, its second has completed phase I clinical testing for cancer, and these are followed by more than forty additional drug candidates that the company believes should provide Bionovo with a sustainable development pipeline of new chemical entities and botanicals.

Nuritas focuses in the discovery and development of bioactive peptides for various industries using artificial intelligence. It's offerings include peptide-based ingredients for dietary supplements, functional foods and beverages, medical foods, and cosmetics. The company serves the food and beverage, health and wellness, and cosmetics sectors with peptide solutions. It was founded in 2014 and is based in Dublin 2, Ireland.